Safety, quality & education

Data sharing statements in five high-impact anesthesiology journals (2020–2023): a cross-sectional study

Can J AnaesthPublished Cross-sectional study

Authors' conclusion

We found that DSS were underused in leading anesthesiology journals.

Study context

Population
Research articles published in five high-impact anesthesiology journals, 2020–2023included articles
Participants
1,123 articles
Outcome
Presence, quality and accessibility of data sharing statements (DSS)
Methodological detailsArticles screened in duplicate (Rayyan); data extracted with a structured Google Form, Large language model (ChatGPT, GPT-4) used for exploratory thematic development of data sharing statements (DSS), with manual validation
  • Articles screened in duplicate (Rayyan); data extracted with a structured Google Form
  • Large language model (ChatGPT, GPT-4) used for exploratory thematic development of DSS, with manual validation

Main finding

As reported in the abstract

DSS prevalence

Anaesthesia, Critical Care & Pain Medicine: articles with DSS in 2020

15%

4/26

Anaesthesia, Critical Care & Pain Medicine: articles with DSS in 2023

30%

9/30

Anesthesia & Analgesia: DSS prevalence

below 8%

Observational data: associations, not effects.

Further findings

Factors associated with DSS inclusion

Government funding, more likely to include DSS (β)
0.734, P = 0.047
Higher journal impact factor, negatively associated with DSS inclusion (β)
−0.298, P = 0.008

DSS type (thematic analysis)

"Conditional Data Availability", most frequent DSS type
74%

Author responses to data requests

Contacted authors who responded
28%
Contacted authors who agreed to share data for replication
14%

Original publication

Data sharing statements in five high-impact anesthesiology journals (2020–2023): a cross-sectional study. Can J Anaesth. Published 10 April 2026. doi:10.1007/s12630-026-03093-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.